Osteoporosis: Prevention, diagnosis, and management

American Journal of Medicine

Volumn 102, Issue 1 A, 1997, Pages

  Deal, Chad L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CAFFEINE; CALCITONIN; CALCIUM; ESTROGEN; ETIDRONIC ACID; FLUORIDE SODIUM; VITAMIN D;

BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; CALCIUM INTAKE; CIGARETTE SMOKING; CLINICAL TRIAL; CONFERENCE PAPER; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; EXERCISE; FEMALE; HIP FRACTURE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MASTALGIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN INTAKE; RISK FACTOR; VAGINA BLEEDING; VITAMIN D DEFICIENCY;

EID: 0031048478     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00415-4     Document Type: Conference Paper

References (23)

1. Sabatier JP, Guaydier-Souguieres G, Laroche D, et al. Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10-24 years of age. Osteoporosis Int. 1996;6:141-148.
2. Felson DT, Zhang Y, Marian T, et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 1993;329:1141-1146.
3. Christiansen C, Lidsay R. Estrogens, bone loss and preservation. Osteoporosis Int. 1990;1:7-13.
4. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1993;94;646-650.
5. Slemenda CW, Hui SL, Longcope C, Wellman H, Johnson CC. Predictors of bone mass in perimenopausal women. A prospective study of clinical data using photon-absorptiometry. Ann Intern Med. 1990;112:96-101.
6. World Health Organization. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. Report of a WHO Study Group. Technical Report Series 843. Geneva: World Health Organization, 1994.
7. Cummings SR, Black DM, Rubin SM. Lifetime risk of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med. 1989;149:2445-2448.
8. Posteson A, Rosenthal D, Melton J, Weinstein M. Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy. Ann Intern Med. 1990;113:593-603.
9. Hui SL, Slemenda CW, Johnston CC. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81:1804-1809.
10. Ross PD, Davis JW, Epstein RS, Washnich RD. Preexisting fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114:919-923.
11. Cummings S, Nevitt M, Browner W, et al. Risk factors for hip fracture in white women. N Engl J Med. 1995;332:767-773.
12. Jensen J, Christiansen C, Rodbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med. 1985;313:973-975.
13. Krall EA, Dawson-Hughes B. Smoking and bone loss among postmenopausal women. J Bone Min Res. 1991;6:331-338.
14. Hayes WC, Piazza SJ, Zysset PK. Biomechanics of fracture risk prediction of the hip and spine by quantitative computed tomography. Radiol Clin North Am. 1991;29:1-18.
15. Quigley MET, Martin PL, Burnier AM, Brooks P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol. 1987;156: 1516-1523.
16. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 1993;329:1141-1146.
17. Odell WD, Heath H. Osteoporosis: pathophysiology, prevention, diagnosis, and treatment. Disease-a-Month. 1993;39:791-867.
18. Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med. 1995;333:1437-1443.
19. Black DM, Cummings SR, Karpf DB, et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535-1541.
20. Riggs CB, Hodgson SF, O'Fallon M, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med. 1990;322:802-809.
21. Pak C, Khashayar S, Damas-Huet B, Piziak V, Peterson R, Poindexter J. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Ann Intern Med. 1995;123:401-408.
22. Aloia JR, Vaswani A, Yeh JK, et al. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med. 1994;120:97-103.
23. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis: a comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med. 1991;325:1189-1195.